Fiala

Peptide library › Immune & inflammation

Icatibant

Also known as Firazyr, Sajazir

FDA-approved drugImmune & inflammation

Self-injected treatment for sudden swelling attacks in hereditary angioedema.

What people use it for

What Icatibant does in the body

Blocks the bradykinin B2 receptor, so bradykinin can't cause the leaky blood vessels and swelling of an attack.

Strength of evidence

Strong: Phase 3 trials (FAST-1, FAST-2 and FAST-3).

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved in 2011; generic versions are available. Can be self-injected after training.

How it's taken

Route: Injection under the skin of the abdomen during an attack

How long it lasts (half-life): About 1.5 hours

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Icatibant privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Icatibant in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Immune & inflammation